Julien Laurent Selected Research

EMD 521873

1/2013	T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.
1/2013	A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julien Laurent Research Topics

Disease

7	Neoplasms (Cancer) 03/2015 - 11/2010
4	Melanoma (Melanoma, Malignant) 04/2014 - 03/2008
2	Fatigue 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 08/2012 - 06/2011
2	Neoplasm Metastasis (Metastasis) 08/2012 - 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Acidosis 02/2014
1	Infections 01/2013
1	Necrosis 01/2013
1	Testicular Neoplasms (Testicular Cancer) 09/2010
1	Down Syndrome (Down's Syndrome) 06/2006

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2013
2	Fc Receptors (Fc Receptor)IBA 01/2020 - 11/2010
2	EMD 521873IBA 01/2013 - 01/2013
2	Interleukin-2 (IL2)IBA 01/2013 - 01/2013
2	AntigensIBA 01/2013 - 09/2010
1	evobrutinibIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	NitratesIBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	CitrullineIBA 01/2019
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Peptides (Polypeptides)IBA 04/2014
1	human soluble LAG-3 proteinIBA 04/2014
1	Coloring Agents (Dyes)IBA 02/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2013
1	A-Form DNA (A-DNA)IBA 01/2013
1	Stem Cell FactorIBA 08/2012
1	Tyrosine Kinase InhibitorsIBA 08/2012
1	Conditioned Culture MediaIBA 06/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	MART-1 AntigenIBA 09/2010
1	Superoxide Dismutase-1IBA 06/2006

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2015 - 03/2008
2	Radiotherapy 01/2015 - 08/2012
2	Immunotherapy 04/2014 - 03/2008
1	Transcranial Magnetic Stimulation 01/2019
1	Therapeutics 01/2011